Tuesday, 28 April 2020

Connecting the dots between heart disease, potential for worse COVID-19 outcomes

People with certain heart diseases may be more susceptible to worse outcomes with COVID-19, but the reason why has remained unknown. New research from Mayo Clinic indicates that in patients with one specific type of heart disease obstructive hypertrophic cardiomyopathy (HCM) the heart increases production of the ACE2 RNA transcript and the translated ACE2 protein.



source https://www.pharmatutor.org/pharma-news/2020/connecting-the-dots-between-heart-disease-potential-for-worse-covid-19-outcomes

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...